salol gran (3ch-30ch) tablet
homeocan inc. - phenyl salicylate - tablet - 3ch - phenyl salicylate 3ch - homeopathic products
salol syrup
cosmic pharma ltd. - salbutamol - syrup - 2 mg/5 ml
salol syrup
salbutamol sulphate - syrup - 2mg/5ml - salbutamol
tox-chord- alfalfa, alumina, benzoicum ac, carboneum, cetraria, folliculinum, fucus, fumaricum ac, hepar suis, kali carb, kreoso
energetix corporation - alfalfa (unii: djo934brbd) (alfalfa - unii:djo934brbd), aluminum oxide (unii: lmi26o6933) (aluminum oxide - unii:lmi26o6933), benzoic acid (unii: 8skn0b0mim) (benzoic acid - unii:8skn0b0mim), d&c black no. 2 (unii: 4xyu5u00c4) (d&c black no. 2 - unii:4xyu5u00c4), cetraria islandica subsp. islandica (unii: bj7ypn79a1) (cetraria islandica subsp. islandica - unii:bj7ypn79a1), estrone (unii: 2di9ha706a) (estrone - unii:2di9ha706a), fucus vesiculosus (unii: 535g2abx9m) (fucus vesiculosus - unii:53 - alfalfa 4 [hp_x] in 59.1 ml - uses temporary relief of occasional cough, headaches, skin eruptions, nausea.
tox-chord (alfalfa, alumina, benzoicum acidum, carboneum, cetraria islandica, folliculinum, fucus vesiculosus, fumaricum acidum,
energetix corp - alfalfa (unii: djo934brbd) (alfalfa - unii:djo934brbd), aluminum oxide (unii: lmi26o6933) (aluminum oxide - unii:lmi26o6933), benzoic acid (unii: 8skn0b0mim) (benzoic acid - unii:8skn0b0mim), d&c black no. 2 (unii: 4xyu5u00c4) (d&c black no. 2 - unii:4xyu5u00c4), cetraria islandica subsp. islandica (unii: bj7ypn79a1) (cetraria islandica subsp. islandica - unii:bj7ypn79a1), estrone (unii: 2di9ha706a) (estrone - unii:2di9ha706a), fucus vesiculosus (unii: 535g2abx9m) (fucus vesiculosus - unii:53 - temporary relief of difficult respiration, headaches, skin eruptions, nausea. temporary relief of difficult respiration, headaches, skin eruptions, nausea.
tox-chord (alfalfa, alumina, benzoicum acidum, carboneum, cetraria islandica, folliculinum, fucus vesiculosus, fumaricum acidum,
energetix corp - alfalfa (unii: djo934brbd) (alfalfa - unii:djo934brbd), aluminum oxide (unii: lmi26o6933) (aluminum oxide - unii:lmi26o6933), benzoic acid (unii: 8skn0b0mim) (benzoic acid - unii:8skn0b0mim), d&c black no. 2 (unii: 4xyu5u00c4) (d&c black no. 2 - unii:4xyu5u00c4), cetraria islandica subsp. islandica (unii: bj7ypn79a1) (cetraria islandica subsp. islandica - unii:bj7ypn79a1), estrone (unii: 2di9ha706a) (estrone - unii:2di9ha706a), fucus vesiculosus (unii: 535g2abx9m) (fucus vesiculosus - unii:53 - temporary relief of difficult respiration, headaches, skin eruptions, nausea. temporary relief of difficult respiration, headaches, skin eruptions, nausea.
uroav-b- methenamine, sodium phosphate, monobasic, anhydrous, phenyl salicylate, methylene blue and hyoscyamine sulfate capsule
avkare - methenamine (unii: j50oix95qv) (methenamine - unii:j50oix95qv), sodium phosphate, monobasic, anhydrous (unii: kh7i04hpuu) (sodium cation - unii:lyr4m0nh37), phenyl salicylate (unii: 28a37t47qo) (phenyl salicylate - unii:28a37t47qo), methylene blue (unii: t42p99266k) (methylene blue cation - unii:zmz79891zh), hyoscyamine sulfate (unii: f2r8v82b84) (hyoscyamine - unii:px44xo846x) - methenamine 118 mg - uroav-b capsules are indicated for the treatment of symptoms of irritative voiding. indicated for the relief of local symptoms, such as inflammation, hypermotility, and pain, which accompany lower urinary tract infections. indicated for the relief of urinary tract symptoms caused by diagnostic procedures. uroav-b capsules are contraindicated in patients with a hypersensitivity to any of the ingredients. risk-benefit should be considered when the following medical problems exist: cardiac disease (especially cardiac arrhythmias, congestive heart failure, coronary heart disease, and mitral stenosis); gastrointestinal tract obstructive disease; glaucoma; myasthenia gravis; acute urinary retention may be precipitated in obstructive uropathy (such as bladder neck obstruction due to prostatic hypertrophy).
uro-mp- methenamine, sodium phosphate, monobasic, anhydrous, phenyl salicylate, methylene blue and hyoscyamine sulfate capsule
method pharmaceuticals, llc - methenamine (unii: j50oix95qv) (methenamine - unii:j50oix95qv), sodium phosphate, monobasic, anhydrous (unii: kh7i04hpuu) (sodium cation - unii:lyr4m0nh37), phenyl salicylate (unii: 28a37t47qo) (phenyl salicylate - unii:28a37t47qo), methylene blue (unii: t42p99266k) (methylene blue cation - unii:zmz79891zh), hyoscyamine sulfate (unii: f2r8v82b84) (hyoscyamine - unii:px44xo846x) - methenamine 118 mg - uro-mp capsules are indicated for the treatment of symptoms of irritative voiding. indicated for the relief of local symptoms, such as inflammation, hypermotility, and pain, which accompany lower urinary tract infections. indicated for the relief of urinary tract symptoms caused by diagnostic procedures. uro-mp capsules are contraindicated in patients with a hypersensitivity to any of the ingredients. risk-benefit should be considered when the following medical problems exist: cardiac disease (especially cardiac arrhythmias, congestive heart failure, coronary heart disease, and mitral stenosis); gastrointestinal tract obstructive disease; glaucoma; myasthenia gravis; acute urinary retention may be precipitated in obstructive uropathy (such as bladder neck obstruction due to prostatic hypertrophy).
uramit mb methenamine sodium phosphate monobasic monohydrate phenyl salicylate methylene blue and hyoscyamine sulfate capsule
burel pharmaceuticals, inc - methenamine (unii: j50oix95qv) (methenamine - unii:j50oix95qv) - methenamine 118 mg
hyolev mb hyoscyamine sulfate methenamine methylene blue phenyl salicylate and sodium phosphate monobasic monohydrate tablet
burel pharmaceuticals, inc - hyoscyamine sulfate (unii: f2r8v82b84) (hyoscyamine - unii:px44xo846x) - hyoscyamine sulfate 0.12 mg